The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTyson Perez, DC, PhD

About this trial

The main aim of this pilot trial is to investigate the feasibility of undertaking a randomized controlled trial involving adults living with HIV. Additionally, this trial will explore potential change differences in self-reported quality of life and blood-derived immune markers between a chiropractic care group and no treatment controls.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 or older

Medically confirmed HIV diagnosis

Willing to complete online surveys

Willing to share lab results

Disqualifiers

Participating in another clinical/behavioral trial related to HIV

Receiving chiropractic care elsewhere

Involved in litigation related to a physical, health-related injury

Has severe osteoporosis or recent spinal fracture

Trial design

Design model

Parallel

Treatments tested in this trial

  • Chiropractic Care

    Procedure/Surgery

    Full-spine Chiropractic Care

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: ChiropracticExperimental treatment 1 intervention
Group B: ControlsNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Proportion of eligible individuals enrolled

The number of eligible individuals (i.e., people who pass the online screen) who enroll (i.e., sign the consent form), divided by the total number of eligible individuals. This assesses 'Enrollment'.

Time frame
From online screen submission to enrollment (up to 2 weeks).
2

Proportion of trial participants complying with instructions

The number of trial participants submitting the online assessments within the submission window, divided by the total number of trial participants. This assesses 'Compliance'.

Time frame
From enrollment to the end of participation (up to 6 months).
3

Proportion of chiropractic participants adhering to the care plan

The number of trial participants randomized to chiropractic care attending at least 90% of their scheduled chiropractic sessions, divided by the total number of trial participants randomized to chiropractic care. This assesses 'Adherence'.

Time frame
From enrollment to the end of participation (up to 6 months)
4

Proportion of chiropractic participants retained

The number of trial participants randomized to chiropractic care who complete the 3rd and final assessments, divided by the total number of trial participants randomized to chiropractic care.

Time frame
From enrollment to the end of the 6 month trial period

Secondary outcomes

1

Change difference in the Short Form 12 Health Survey (SF-12)

Change difference in SF-12 scores between the chiropractic and control groups. The SF-12 is a validated, 12-item self-report designed to measure health-related quality of life (HRQoL). The SF-12 uses T-scores with a score of 50 representing the population mean.

Time frame
Baseline, 12 weeks, 24 weeks
2

Change difference in the General Pain Index (GPI)

Change difference in GPI scores between the chiropractic and control groups. The GPI is a validated, 6-item self-report that asks patients to rate how much pain has interfered with functioning across various aspects of life on a scale of 0 (completely able to function) to 10 (totally unable to function)

Time frame
Baseline, 12 weeks, 24 weeks
3

Change difference in CD4 count

Change difference in CD4 counts between the chiropractic and control groups. CD4 count is a lab test that measures the number of CD4 T-lymphocytes (also called "helper T-cells") in a cubic millimeter of blood.

Time frame
Baseline; 12 weeks; 24 weeks
4

Change difference in CD4/CD8 ratio

Change difference in CD4/CD8 ratios between the chiropractic and control groups. CD4/CD8 ratio is calculated by dividing the number of CD4 cells ("helper T-cells") in a cubic millimeter of blood by the number of CD8 cells ("killer T-cells") in a cubic millimeter of blood.

Time frame
Baseline; 12 weeks; 24 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tyson Perez, DC, PhD

Lead sponsor

Life University

Sponsor institution